Adamis Pharmaceuticals (ADMP) Open to New Partnerships for EpiPen Alternative; Targets New NDA Submission by Year End - Bloomberg

August 26, 2016 4:17 PM EDT
Get Alerts ADMP Hot Sheet
Trade ADMP Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Adamis Pharmaceuticals (NASDAQ: ADMP) Open to New Partnerships for EpiPen Alternative; Targets New NDA Submission by Year End - Bloomberg



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Management Comments, Momentum Movers

Add Your Comment